Phyllis Yan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease”.

Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease

Urology(2022)10.1016/j.urology.2022.04.031

N/A

0DataRank · unranked

9 citations

Phyllis Yan, Joseph J. Crivelli, David S. Goldfarb, Vahakn B. Shahinian, John M. Hollingsworth +1 more

Comparison of Selective vs Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence With High-Risk Features

Urology(2022)10.1016/j.urology.2021.12.037

N/A

0DataRank · unranked

13 citations

Phyllis Yan, Joseph J. Crivelli, David S. Goldfarb, Vahakn B. Shahinian, John M. Hollingsworth +1 more

Changes in Shared Savings Program Participation After Launch of Pathways to Success

Journal of General Internal Medicine(2022)10.1007/s11606-022-07947-x

N/A

0DataRank · unranked

5 citations

Richard A. Hirth, Phyllis Yan, Addison Shay, Sitara Murali, Andrew M. Ryan +2 more

Comparison of Class-Specific Side Effects Across Preventative Pharmacologic Therapies for Kidney Stone Disease

Urology Practice(2023)10.1097/upj.0000000000000470

N/A

0DataRank · unranked

8 citations

Joseph J. Crivelli, Phyllis Yan, Vahakn B. Shahinian, John M. Hollingsworth, Ryan S. Hsi

Associations of Topiramate and Zonisamide Use With Kidney Stones: A Retrospective Cohort Study

American Journal of Kidney Diseases(2025)10.1053/j.ajkd.2024.12.009

N/A

0DataRank · unranked

9 citations

Mary Oerline, Phyllis Yan, Ryan S. Hsi, Joseph J. Crivelli, John R. Asplin +3 more